The U.S. Food and Drug Administration (FDA) has granted Paige, a technology company that supports cancer diagnosis, Breakthrough Device Designation for its artificial intelligence application, Paige Lymph Node. The Breakthrough Device Designation is awarded to technologies with the potential to improve diagnosis or treatment of life-threatening diseases.